Chronopharmacokinetics of Imipramine and Desipramine in Rat Forebrain and Plasma After Single and Chronic Treatment with Imipramine
- 1 January 1991
- journal article
- Published by Taylor & Francis in Chronobiology International
- Vol. 8 (3) , 176-185
- https://doi.org/10.3109/07420529109063924
Abstract
Daily variations in the pharmacokinetics of imipramine (IMI) could contribute to circadian phase-dependent effects of the drug. Therefore, the chronopharmacokinetics of IMI and its metabolite, desipramine (DMI), were studied after single and chronic application. Male rats were synchronized to a 12:12 hour light:dark (L:D) regimen with lights on from 07:00 to 19:00 (dark, 19:00-07:00). In single-dose experiments rats were injected with IMI (10 mg/kg) i.p. or i.v. at 07:30 or 19:30 and groups of rats were killed 0-22 hours thereafter. After chronic application of IMI in drinking water (approximately 15 mg/kg/d) groups of rats were killed during the 14th day of treatment at 02:00, 08:00, 14:00, and 20:00, respectively. Brain and plasma concentrations of IMI and DMI were determined by reversed-phase high-performance liquid chromatography with ultraviolet detection. After single i.p. application of IMI, maximal brain concentrations (Cmax) of IMI and DMI were nearly twofold higher in darkness (IMI, 4.8 micrograms/g; DMI, 1.8 micrograms/g) than in light (IMI, 2.85 micrograms/g; DMI, 0.85 microgram/g). Also, the area under the curve (AUC) (0-22 hours) was about 1.6-fold greater in darkness than in light for IMI and DMI; half-lives were not circadian phase dependent. After i.v. injection of IMI, the AUC in brain was also about 30% greater in darkness than in light. After chronic application of IMI in drinking water, brain concentrations of IMI and DMI varied more than threefold within 24 hours. The data demonstrate that the pharmacokinetics of IMI and DMI are circadian phase dependent. It is assumed that circadian variations in drug distribution are more likely to contribute to the drug's chronopharmacokinetics than variations in the drug's metabolism. The 24-hour variations in the drug's concentrations after chronic IMI application in drinking water can be explained by the drinking behavior of the rats, which by itself is altered by IMI.Keywords
This publication has 15 references indexed in Scilit:
- Determination of citalopram in plasma and brain tissue of the rat by high-performance liquid chromatography with ultraviolet detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1989
- Regional distribution and elimination kinetics of imipramine in rat brain after a single intraperitoneal administration.CHEMICAL & PHARMACEUTICAL BULLETIN, 1985
- Different pharmacokinetic and pharmacological effects following acute and chronic treatment with imipramineJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1982
- Circadian Changes of Drug Disposition in ManClinical Pharmacokinetics, 1982
- Down regulation of dihydroalprenolol and imipramine binding sites in brain of rats repeatedly treated with imipramineEuropean Journal of Pharmacology, 1980
- Circadian rhythms in rat brain alpha- and beta-adrenergic receptors are modified by chronic imipramineLife Sciences, 1980
- Specific tricyclic antidepressant binding sites in rat brain characterised by high-affinity 3H-imipramine bindingEuropean Journal of Pharmacology, 1980
- Influence of phenobarbital on the distribution and elimination of desmethylimipramine in the ratBiochemical Pharmacology, 1977
- Effects of some antidepressant drugs on the depletion of intraneuronal brain catecholamine stores caused by 4,α-dimethyl-meta-tyramineEuropean Journal of Pharmacology, 1969
- Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-α-ethyl-meta-tyramineEuropean Journal of Pharmacology, 1969